Sofinnova Investments, Inc. - VERA THERAPEUTICS INC ownership

VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 32 filers reported holding VERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of VERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,534,709
-14.6%
3,467,1560.0%3.00%
-17.7%
Q2 2023$55,647,854
+106.8%
3,467,1560.0%3.64%
+111.8%
Q1 2023$26,905,131
-56.3%
3,467,156
+9.0%
1.72%
-52.9%
Q4 2022$61,560,903
-9.2%
3,181,4420.0%3.65%
-7.4%
Q3 2022$67,797,000
+56.6%
3,181,4420.0%3.94%
+9.4%
Q2 2022$43,299,000
-42.1%
3,181,4420.0%3.61%
-36.4%
Q1 2022$74,732,000
-4.0%
3,181,442
+9.1%
5.67%
+24.7%
Q4 2021$77,883,000
+54.0%
2,914,7760.0%4.55%
+51.9%
Q3 2021$50,571,000
+30.8%
2,914,7760.0%3.00%
+34.4%
Q2 2021$38,650,0002,914,7762.23%
Other shareholders
VERA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,372,428$26,170,0413.38%
COMMODORE CAPITAL LP 2,824,029$21,914,4653.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,002,257$7,747,4472.16%
Sofinnova Investments, Inc. 3,467,156$26,905,1311.72%
Altium Capital Management LP 286,000$2,219,3601.23%
Eversept Partners, LP 1,788,529$13,878,9850.97%
SECTORAL ASSET MANAGEMENT INC 600,300$4,658,3280.90%
Octagon Capital Advisors LP 795,000$6,169,2000.89%
Carlyle Group Inc. 2,960,231$22,882,5860.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,300,000$10,088,0000.22%
View complete list of VERA THERAPEUTICS INC shareholders